Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The workshop was  attended by both experienced and novice clinical researchers, surgeons, research nurses and the odd Channel 4 newsreader! Jon Snow gave a talk about the role media can play in promoting clinical research.

NDORMS were well represented at the event, with Head of department Professor Andrew Carr presenting on “Challenges with surgical trials” and Professor David Beard speaking about the 'Can Shoulder Arthroscopy Work?' study (CSAW); Professor Beard also highlighted other studies from the NDORMS Surgical Intervention Trials Unit (SITU) portfolio. Naomi Merritt and Cushla Cooper, from the CSAW study hosted a breakout session in collaboration with colleagues from the University of Bristol; their session focused on the perils of recruiting patients to studies and they presented work from the Qualitative Recruitment Investigation that was included in the CSAW study.

The event showed how far we have come in the world of surgical research and it was very rewarding for the SITU team to see how the increasing portfolio of orthopaedic and plastics trials in the its portfolio (UKUFF, TOPKAT, CSAW, NINJA) has helped shape current orthopaedic surgical trials research. The day also provided an excellent opportunity for the Oxford group to share their knowledge and experience with the wider orthopaedic community and the team are very much looking forward to sponsoring more of these events and, along with a strong partnership with the British Orthopaedic Association unit at York, help move orthopaedic research into the future.

The RCS day was supplemented by a Trauma and Orthopaedics trials day and Trauma Society special interest day hosted by Professor Matt Costa in Warwick. Again, Oxford had good representation with David Beard speaking on behalf of SITU.

The day was sponsored jointly by the RCS, the Oxford Surgical Intervention Trials Unit at NDORMS and the British Orthopaedic Association Orthopaedic Surgery Research Centre (York Trials Unit).

If you have any comments on the day or would like to find out more, please contact Cushla Cooper, SITU Portfolio Manager (Orthopaedics & Plastics).

Similar stories

The new Botnar strategy is announced

After a year as the Director of the Botnar Institute for Musculoskeletal Sciences, Professor Jonathan Rees announces a new structure and strategy that will further enhance research and treatment of bone, joint and musculoskeletal conditions.

New global health grant to improve outcomes for patients with hip fracture

Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.

NDORMS welcomes great-granddaughter of former Head of Department

Julia Strubell, great-granddaughter of Professor Josep Trueta, visited NDORMS to find out about his time here and to share her own work with staff and students.

Botnar researchers awarded Fellowships

Arani Vivekanantham has been awarded an NIHR Doctoral Fellowship and a Versus Arthritis Clinical Research Fellowship, and Rachel Kuo was awarded an NIHR Doctoral Research Fellowship.

Better diagnosis and treatment of autoimmune diseases moves a step closer

A study published in Nature outlines a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to them.

New drug offers hope for people with hand osteoarthritis

A new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.